Phocas Financial Corp. Myriad Genetics Inc Transaction History

Phocas Financial Corp.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	BUY	$18.21 - $27.88 $50,186 - $76,837	2,756 Added 2.15%	130,705 $2.49 Million
Q2 2022 Aug 15, 2022	SELL	$16.45 - $25.88 $24,444 - $38,457	-1,486 Reduced 1.15%	127,949 $2.33 Million
Q1 2022 May 25, 2022	SELL	$22.67 - $28.01 $60,438 - $74,674	-2,666 Reduced 2.02%	129,435 $3.26 Million
Q4 2021 Feb 15, 2022	SELL	$24.13 - $32.63 $76,395 - $103,306	-3,166 Reduced 2.34%	132,101 $3.65 Million
Q3 2021 Nov 16, 2021	BUY	$29.97 - $36.66 $826,212 - $1.01 Million	27,568 Added 25.6%	135,267 $4.37 Million
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $2.73 Million - $3.51 Million	107,699 New	107,699 $3.29 Million
Q1 2019 May 13, 2019	SELL	$26.93 - $34.7 $3,231 - $4,164	-120 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$27.23 - $45.56 $3,267 - $5,467	120 New	120 $3,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.09B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.